PathoBiology Group (PBG) is a team of cancer researchers working on the problems of biomarker development in malignant tumors of different origins. PBG members conduct a number of the pre-clinical and clinical studies that could markedly contribute to improvement of clinical outcome in cancer patients.
PBG members collaborate with each other and invite other researchers to join the ongoing projects of the PBG.
PBG Executive Committee
PBG Chair: Ira-Ida Skvortsova, Medical University of Innsbruck, Austria
PBG Secretary: Leticia Oliveira-Ferrer, Universitäts-Klinikum Hamburg Eppendorf, Germany
PBG Treasurer: Maurizio Callari, Cancer Research UK Cambridge Institute, University of Cambridge, UK
PBG Steering Committee
Biorepositories Chair: M.G.Daidone, A. Paradiso
QA Biomarker and NGS Chairs: F.Sweep, E.Rouleau
QA Pathology Chair: R.Salgado
EORTC-NCI(-ASCO) affairs: N.Brünner, N.Harbeck
Clinical affairs: S.Slejfer, N.Harbeck, C.Thomssen
Basic affairs: J.Kos
Young Investigator Tumor Biology: L.Oliveira-Ferrer, T.Gevaert
Young Investigator Pathology: G.van den Eynden
Bioinformatics: M. Callari
EORTC PathoBiology Group Steering committee will be re-elected in November 2020